Перегляд за Автор "Heissig, Beate"

Зараз показуємо 1 - 1 з 1
  • Ескіз недоступний
    Документ
    Interleukin-10 induces TNF-driven apoptosis and ROS production in salivary gland cancer cells
    (Heliyon, 2024) Skrypnyk, Maksym; Yatsenko, Tetiana; Riabets, Oleksandra; Salama, Yousef; Skikevych, Margarita; Osada, Taro; Tobita, Morikuni; Takahashi, Satoshi; Hattori, Koichi; Heissig, Beate; Скрипник, Максим Ігорович; Скікевич, Маргарита Георгіївна
    Treatment resistance after chemo-/immunotherapy occurs in patients with head and neck squamous cell cancers (HNSCs), including salivary gland cancers (SGCs). Interleukin-10 (IL-10), a cytokine with pro- and anti-cancer effects, has an unclear impact on HNSC/SGC cells. We show that HNSC patients exhibiting high expression of IL-10 and its receptor IL-10Rα experience have prolonged overall survival. Immunoreactive IL-10 was low in ductal cells of human SGC biopsies. Human (A253) and murine WR21-SGC cells expressed IL-10Rβ, but only A253 cells expressed IL-10 and IL-10Rα. The addition of recombinant IL-10 impaired SGC cell proliferation and induced apoptosis in vitro. N-acetylcysteine restored IL-10-induced reactive oxygen species (ROS) production but did not prevent IL-10-mediated viability loss. Mechanistically, recIL-10 delayed cell cycle progression from G0/G1 to the S phase with cyclin D downregulation and upregulation of NF-kB. IL-10 increased tumor necrosis factor-α (TNF-α) in A253 and WR21 and FasL in WR21 cells. Neutralizing antibodies against TNF-α and NF-kB inhibition restored SGC proliferation after IL-10 treatment, emphasizing the critical role of TNF-α and NF-kB in IL-10-mediated anti-tumor effects. These findings underscore the potential of IL-10 to impede SGC cell growth through apoptosis induction, unraveling potential therapeutic targets for intervention in salivary gland carcinomas.